Slipro en es it fr

Slipro Brand names, Slipro Analogs

Slipro Brand Names Mixture

  • No information avaliable

Slipro Chemical_Formula


Slipro RX_link

Slipro fda sheet

Slipro FDA

Slipro msds (material safety sheet)

Slipro Synthesis Reference

No information avaliable

Slipro Molecular Weight

387.711 g/mol

Slipro Melting Point

No information avaliable

Slipro H2O Solubility

No information avaliable

Slipro State


Slipro LogP


Slipro Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Slipro Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Slipro Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Slipro Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Slipro side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Slipro Patient Information

Slipro Organisms Affected

Yeast and other fungi